SODIUM PHENYLBUTYRATE TABLETS, 500 MG

SODIUM PHENYLBUTYRATE TABLETS, 500 MG was reported 154 times

SODIUM PHENYLBUTYRATE TABLETS, 500 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OROTICACIDURIA 1 0.0714
1 ORNITHINE TRANSCARBAMOYLASE DEFICIENCY 2 0.0488
2 METASTASES TO REPRODUCTIVE ORGAN 1 0.0385
3 HYPERAMMONAEMIC CRISIS 4 0.0374
4 UREA CYCLE DISORDER 1 0.0208
5 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
6 DRUG METABOLITE LEVEL HIGH 1 0.0119
7 CATHETER SITE OEDEMA 1 0.0092
8 DRUG NAME CONFUSION 1 0.0079
9 DENTAL PROSTHESIS USER 1 0.0079
10 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 1 0.0068
11 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
12 GASTROINTESTINAL MUCORMYCOSIS 1 0.0060
13 CARNITINE DEFICIENCY 1 0.0058
14 MENINGORRHAGIA 1 0.0040
15 DRUG LABEL CONFUSION 1 0.0040
16 KYPHOSCOLIOSIS 1 0.0038
17 HYPERAMMONAEMIA 18 0.0036
18 POST PROCEDURAL PNEUMONIA 1 0.0033
19 HEPATITIS ALCOHOLIC 1 0.0031
20 AMINO ACID LEVEL DECREASED 1 0.0030
21 MENTAL RETARDATION 1 0.0028
22 MILIA 1 0.0028
23 HEMIANOPIA HOMONYMOUS 2 0.0027
24 DISSEMINATED MUCORMYCOSIS 1 0.0025
25 MENINGEAL DISORDER 1 0.0025
26 LARYNGEAL PAIN 1 0.0025
27 NECROTISING ENTEROCOLITIS NEONATAL 1 0.0025
28 BONE SCAN ABNORMAL 1 0.0024
29 NECROSIS ISCHAEMIC 1 0.0022
30 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
31 AMMONIA INCREASED 9 0.0018
32 URINARY TRACT INFECTION FUNGAL 1 0.0017
33 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
34 AORTIC CALCIFICATION 1 0.0017
35 AMBLYOPIA 1 0.0017
36 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
37 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
38 OEDEMA GENITAL 1 0.0016
39 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
40 THYROID HORMONES DECREASED 1 0.0013
41 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
42 TESTICULAR ATROPHY 1 0.0011
43 MUCOSAL ULCERATION 1 0.0010
44 SOFT TISSUE DISORDER 1 0.0009
45 PARESIS 2 0.0009
46 MOANING 1 0.0009
47 MICROCEPHALY 1 0.0008
48 TRANSCRIPTION MEDICATION ERROR 1 0.0006
49 OSTEOSCLEROSIS 1 0.0006
50 RESPIRATORY ALKALOSIS 1 0.0006
51 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
52 FOOD AVERSION 1 0.0006
53 LIVER TRANSPLANT REJECTION 1 0.0006
54 BONE LESION 2 0.0006
55 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
56 PURULENCE 1 0.0005
57 ANAEMIA MACROCYTIC 1 0.0005
58 PERFORMANCE STATUS DECREASED 2 0.0004
59 URINARY TRACT OBSTRUCTION 1 0.0004
60 EOSINOPHIL COUNT DECREASED 1 0.0004
61 INFREQUENT BOWEL MOVEMENTS 1 0.0004
62 VENTRICULAR HYPERTROPHY 1 0.0004
63 CATHETER SITE PAIN 1 0.0004
64 MUCORMYCOSIS 1 0.0004
65 HYPERLACTACIDAEMIA 1 0.0004
66 BRADYPNOEA 1 0.0004
67 CLONUS 1 0.0004
68 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
69 STRABISMUS 1 0.0003
70 PROTHROMBIN TIME PROLONGED 2 0.0003
71 LOOSE TOOTH 1 0.0003
72 PORTAL VEIN THROMBOSIS 1 0.0003
73 DEAFNESS NEUROSENSORY 1 0.0003
74 PROSTATE CANCER METASTATIC 1 0.0003
75 METASTASES TO SPINE 1 0.0003
76 NEOPLASM RECURRENCE 1 0.0003
77 METASTASIS 2 0.0003
78 LIVER TRANSPLANT 1 0.0003
79 CEREBRAL DISORDER 2 0.0003
80 PROTEIN TOTAL DECREASED 1 0.0003
81 CLAVICLE FRACTURE 1 0.0003
82 SKIN ODOUR ABNORMAL 1 0.0003
83 SKIN PAPILLOMA 1 0.0002
84 HYPERURICAEMIA 1 0.0002
85 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
86 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
87 METASTATIC NEOPLASM 1 0.0002
88 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
89 PARONYCHIA 1 0.0002
90 BRAIN NEOPLASM 2 0.0002
91 HOSPICE CARE 2 0.0002
92 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
93 ABDOMINAL TENDERNESS 1 0.0002
94 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
95 CACHEXIA 1 0.0002
96 NYSTAGMUS 1 0.0002
97 PRODUCT RESIDUE PRESENT 1 0.0002
98 DEAFNESS UNILATERAL 1 0.0002
99 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
100 INTRACRANIAL PRESSURE INCREASED 1 0.0002
101 PREMATURE LABOUR 1 0.0002
102 HYPERVENTILATION 1 0.0002
103 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
104 DERMATITIS ACNEIFORM 1 0.0002
105 ENCEPHALOPATHY 4 0.0002
106 CARDIOMEGALY 2 0.0002
107 OLIGURIA 1 0.0002
108 SCREAMING 1 0.0002
109 HERPES SIMPLEX 1 0.0002
110 METASTASES TO LYMPH NODES 1 0.0001
111 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
112 LARGE INTESTINE PERFORATION 1 0.0001
113 HEPATOCELLULAR INJURY 2 0.0001
114 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
115 TENDON PAIN 1 0.0001
116 ACIDOSIS 1 0.0001
117 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
118 BLOOD ALBUMIN DECREASED 1 0.0001
119 DECUBITUS ULCER 1 0.0001
120 ABNORMAL FAECES 1 0.0001
121 HAEMODIALYSIS 1 0.0001
122 VITAMIN D DECREASED 1 0.0001
123 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
124 DEVELOPMENTAL DELAY 1 0.0001
125 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
126 ARTERIOSCLEROSIS 1 0.0001
127 INCREASED APPETITE 2 0.0001
128 ATELECTASIS 1 0.0001
129 SINUS BRADYCARDIA 1 0.0001
130 HYPOTONIA 1 0.0001
131 MOTOR DYSFUNCTION 1 0.0001
132 INITIAL INSOMNIA 1 0.0001
133 POOR VENOUS ACCESS 1 0.0001
134 VENTRICULAR EXTRASYSTOLES 1 0.0001
135 PHARYNGITIS STREPTOCOCCAL 1 0.0001
136 GASTROINTESTINAL PAIN 1 0.0001
137 DENTAL CARIES 1 0.0001
138 FOOT DEFORMITY 1 0.0001
139 HEPATOTOXICITY 2 0.0001
140 MALNUTRITION 1 0.0001
141 SKIN INFECTION 1 0.0001
142 INTESTINAL PERFORATION 1 0.0001
143 REBOUND EFFECT 1 0.0001
144 NEOPLASM 1 0.0001
145 SPLENOMEGALY 1 0.0001
146 COMA 4 0.0001
147 MUSCLE RIGIDITY 1 0.0001
148 BURSITIS 1 0.0001
149 GENERALISED OEDEMA 1 0.0001
150 POISONING 1 0.0001
151 BRAIN OEDEMA 1 0.0001
152 ROTATOR CUFF SYNDROME 1 0.0001
153 SKIN ULCER 2 0.0001
154 ADVERSE EVENT 7 0.0001
155 TOOTH INFECTION 1 0.0001
156 HAIR TEXTURE ABNORMAL 1 0.0001
157 GINGIVAL BLEEDING 1 0.0001
158 SKIN LESION 2 0.0001
159 ORAL DISCOMFORT 1 0.0001
160 HUNGER 1 0.0001
161 DEVICE OCCLUSION 1 0.0001
162 DIALYSIS 1 0.0001
163 BRONCHOSPASM 1 0.0001
164 IMPAIRED QUALITY OF LIFE 1 0.0001
165 APHASIA 2 0.0001
166 OSTEOPENIA 1 0.0001
167 BASAL CELL CARCINOMA 1 0.0001
168 BRAIN FOG 1 0.0001
169 PRODUCT USE COMPLAINT 1 0.0001
170 SEIZURE 7 0.0001
171 BLOOD UREA INCREASED 1 0.0001
172 CIRCULATORY COLLAPSE 1 0.0001
173 METRORRHAGIA 1 0.0001
174 MULTI-ORGAN FAILURE 1 0.0001
175 NEOPLASM PROGRESSION 2 0.0001
176 EOSINOPHILIA 1 0.0001
177 LYMPHOCYTE COUNT DECREASED 1 0.0001
178 LYMPHADENOPATHY 2 0.0001
179 OSTEOMYELITIS 1 0.0001
180 HYPERGLYCAEMIA 2 0.0001
181 BONE DISORDER 1 0.0001
182 TREATMENT NONCOMPLIANCE 3 0.0001
183 DYSGEUSIA 4 0.0001
184 HEPATIC STEATOSIS 1 0.0001
185 POST PROCEDURAL COMPLICATION 1 0.0001
186 DISEASE PROGRESSION 6 0.0001
187 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
188 SINUS DISORDER 1 0.0001
189 CATARACT 3 0.0001
190 BLOOD PRESSURE ABNORMAL 1 0.0001
191 PREGNANCY 1 0.0000
192 FEEDING DISORDER 1 0.0000
193 BODY TEMPERATURE INCREASED 1 0.0000
194 RIB FRACTURE 1 0.0000
195 TOOTH LOSS 1 0.0000
196 DERMATITIS 1 0.0000
197 EATING DISORDER 1 0.0000
198 RETCHING 1 0.0000
199 RHINORRHOEA 3 0.0000
200 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
201 TRANSAMINASES INCREASED 1 0.0000
202 TOOTH DISORDER 1 0.0000
203 ORAL PAIN 1 0.0000
204 RASH PAPULAR 1 0.0000
205 PANCREATITIS ACUTE 1 0.0000
206 MUSCLE TWITCHING 1 0.0000
207 ABASIA 1 0.0000
208 OSTEONECROSIS OF JAW 1 0.0000
209 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
210 UNEVALUABLE EVENT 3 0.0000
211 ERECTILE DYSFUNCTION 1 0.0000
212 ILLNESS 4 0.0000
213 HAEMATOMA 1 0.0000
214 DEHYDRATION 5 0.0000
215 PAIN OF SKIN 1 0.0000
216 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
217 RESPIRATORY ARREST 1 0.0000
218 ABNORMAL DREAMS 1 0.0000
219 WOUND 1 0.0000
220 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
222 PAIN IN JAW 1 0.0000
223 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
224 LETHARGY 2 0.0000
225 LIVER FUNCTION TEST ABNORMAL 1 0.0000
226 BONE PAIN 2 0.0000
227 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
228 URINARY INCONTINENCE 1 0.0000
229 RESPIRATORY DISORDER 1 0.0000
230 HEPATIC FAILURE 1 0.0000
231 EPILEPSY 1 0.0000
232 GYNAECOMASTIA 1 0.0000
233 BONE DENSITY DECREASED 1 0.0000
234 CYSTITIS 1 0.0000
235 METABOLIC ACIDOSIS 1 0.0000
236 DEEP VEIN THROMBOSIS 2 0.0000
237 DECREASED APPETITE 7 0.0000
238 NEOPLASM MALIGNANT 2 0.0000
239 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
240 HEPATIC ENZYME INCREASED 2 0.0000
241 GASTRIC DISORDER 1 0.0000
242 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
243 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
244 RESPIRATORY FAILURE 2 0.0000
245 BRONCHITIS 2 0.0000
246 SEPSIS 3 0.0000
247 DEATH 23 0.0000
248 HOT FLUSH 2 0.0000
249 INTESTINAL OBSTRUCTION 1 0.0000
250 COLITIS 1 0.0000
251 DIARRHOEA 17 0.0000
252 ABDOMINAL PAIN 6 0.0000
253 ALOPECIA 5 0.0000
254 ARTHRITIS 2 0.0000
255 DISORIENTATION 1 0.0000
256 SOMNOLENCE 5 0.0000
257 DYSKINESIA 1 0.0000
258 NEUTROPHIL COUNT DECREASED 1 0.0000
259 LUNG NEOPLASM MALIGNANT 1 0.0000
260 CARDIAC ARREST 2 0.0000
261 OFF LABEL USE 21 0.0000
262 OSTEOARTHRITIS 1 0.0000
263 RENAL FAILURE ACUTE 1 0.0000
264 LOSS OF CONSCIOUSNESS 3 0.0000
265 VAGINAL HAEMORRHAGE 1 0.0000
266 TACHYCARDIA 2 0.0000
267 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
268 THROAT IRRITATION 1 0.0000
269 ADVERSE DRUG REACTION 2 0.0000
270 THERAPY NON-RESPONDER 1 0.0000
271 MUSCLE SPASMS 4 0.0000
272 TINNITUS 1 0.0000
273 HYPOKALAEMIA 1 0.0000
274 RENAL DISORDER 1 0.0000
275 BLOOD CHOLESTEROL INCREASED 1 0.0000
276 CARDIAC DISORDER 2 0.0000
277 PRODUCT USE ISSUE 4 0.0000
278 ARRHYTHMIA 1 0.0000
279 PULMONARY EMBOLISM 2 0.0000
280 PRODUCTIVE COUGH 1 0.0000
281 INFECTION 3 0.0000
282 HYPOGLYCAEMIA 1 0.0000
283 DYSPEPSIA 2 0.0000
284 PYREXIA 7 0.0000
285 SYNCOPE 2 0.0000
286 CELLULITIS 1 0.0000
287 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
288 PERIPHERAL SWELLING 3 0.0000
289 ABDOMINAL DISTENSION 2 0.0000
290 HAEMORRHAGE 2 0.0000
291 SPEECH DISORDER 1 0.0000
292 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
293 PLATELET COUNT DECREASED 2 0.0000
294 MEDICATION ERROR 1 0.0000
295 WEIGHT DECREASED 5 0.0000
296 PANCYTOPENIA 1 0.0000
297 NECK PAIN 1 0.0000
298 BLISTER 1 0.0000
299 HYPONATRAEMIA 1 0.0000
300 FLATULENCE 1 0.0000
301 CONVULSION 1 0.0000
302 HERPES ZOSTER 1 0.0000
303 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
304 BLADDER CANCER 1 0.0000
305 IRRITABILITY 1 0.0000
306 THERAPEUTIC RESPONSE DECREASED 1 0.0000
307 CONDITION AGGRAVATED 5 0.0000
308 VERTIGO 1 0.0000
309 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
310 NASOPHARYNGITIS 3 0.0000
311 HYPERSENSITIVITY 3 0.0000
312 RASH 7 0.0000
313 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
314 ABDOMINAL PAIN UPPER 3 0.0000
315 VISION BLURRED 2 0.0000
316 INJURY 1 0.0000
317 SLEEP DISORDER 1 0.0000
318 CONSTIPATION 3 0.0000
319 UNDERDOSE 1 0.0000
320 HALLUCINATION 1 0.0000
321 ACNE 1 0.0000
322 HOSPITALISATION 2 0.0000
323 DRUG DOSE OMISSION BY DEVICE 1 0.0000
324 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
325 PNEUMONIA 4 0.0000
326 DRY MOUTH 1 0.0000
327 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
328 DRUG DOSE OMISSION 2 0.0000
329 TREMOR 2 0.0000
330 ABDOMINAL DISCOMFORT 2 0.0000
331 RENAL IMPAIRMENT 1 0.0000
332 URINARY TRACT INFECTION 2 0.0000
333 DRUG WITHDRAWAL SYNDROME 1 0.0000
334 NAUSEA 9 0.0000
335 GASTROINTESTINAL DISORDER 1 0.0000
336 COUGH 3 0.0000
337 SWELLING 1 0.0000
338 VOMITING 5 0.0000
339 DYSPHAGIA 1 0.0000
340 ANAEMIA 2 0.0000
341 CONTUSION 1 0.0000
342 DRUG INTOLERANCE 1 0.0000
343 FATIGUE 8 0.0000
344 HEART RATE INCREASED 1 0.0000
345 CHEST DISCOMFORT 1 0.0000
346 THROMBOCYTOPENIA 1 0.0000
347 WEIGHT INCREASED 2 0.0000
348 MUSCULAR WEAKNESS 1 0.0000
349 BACK PAIN 2 0.0000
350 CHILLS 1 0.0000
351 FEELING ABNORMAL 2 0.0000
352 OEDEMA PERIPHERAL 1 0.0000
353 VISUAL IMPAIRMENT 1 0.0000
354 DIZZINESS 4 0.0000
355 ASTHENIA 3 0.0000
356 RENAL FAILURE 1 0.0000
357 ANXIETY 2 0.0000
358 DRUG INEFFECTIVE 9 0.0000
359 PAIN IN EXTREMITY 2 0.0000
360 HEADACHE 4 0.0000
361 DRUG INTERACTION 1 0.0000
362 CONFUSIONAL STATE 1 0.0000
363 FALL 2 0.0000
364 TOXICITY TO VARIOUS AGENTS 1 0.0000
365 CEREBROVASCULAR ACCIDENT 1 0.0000
366 COVID-19 1 0.0000
367 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
368 BLOOD GLUCOSE INCREASED 1 0.0000
369 DYSPNOEA 3 0.0000
370 GAIT DISTURBANCE 1 0.0000
371 HYPOTENSION 1 0.0000
372 OVERDOSE 1 0.0000
373 MALAISE 2 0.0000
374 DEPRESSION 1 0.0000
375 PAIN 2 0.0000
376 PRURITUS 1 0.0000
377 ARTHRALGIA 1 0.0000